Galiximab is a monoclonal antibody designed for the treatment of B-cell lymphoma. As of September 2009[update], it is undergoing Phase III clinical trials...
2 KB (104 words) - 00:09, 15 June 2023
Vepalimomab Zolimomab aritox Chimeric Andecaliximab†Basiliximab Clenoliximab Galiximab Gomiliximab Infliximab Keliximab Lumiliximab Priliximab Teneliximab Vapaliximab...
38 KB (4,304 words) - 20:57, 1 December 2023
(EGFR) cancer Galcanezumab Emgality mab humanized calcitonin Y migraine Galiximab mab chimeric CD80 B-cell lymphoma Gancotamab scFv human HER2/neu cancer...
135 KB (4,013 words) - 03:57, 1 June 2024
Lumiliximab CD40 Teneliximab Toralizumab CD62L/L-selectin Aselizumab CD80 Galiximab CD147/Basigin Gavilimomab CD154 Ruplizumab Frexalimab BLyS Belimumab CAT...
7 KB (299 words) - 13:45, 27 April 2024
treat FL include monoclonal antibodies such as rituximab, obinutuzumab, galiximab, inotuzumab ozogamicin, or epratuzumab and immunomodulators such as lenalidomide...
67 KB (7,967 words) - 19:22, 29 April 2024
Vepalimomab Zolimomab aritox Chimeric Andecaliximab†Basiliximab Clenoliximab Galiximab Gomiliximab Infliximab Keliximab Lumiliximab Priliximab Teneliximab Vapaliximab...
2 KB (87 words) - 01:28, 30 May 2023
galamustine (INN) galantamine (INN) galdansetron (INN) galgenprostucel-L (USAN) galiximab (USAN) gallamine triethiodide (INN) Galli Eo Galliapharm gallium (67 Ga)...
14 KB (644 words) - 06:16, 1 June 2024
Lumiliximab CD40 Teneliximab Toralizumab CD62L/L-selectin Aselizumab CD80 Galiximab CD147/Basigin Gavilimomab CD154 Ruplizumab Frexalimab BLyS Belimumab CAT...
38 KB (2,656 words) - 12:11, 30 October 2023